药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rifapentine
Nabiximols
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Nabiximols.
Rifapentine
WIN 55212-2
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with WIN 55212-2.
Rifapentine
Surinabant
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Surinabant.
Rifapentine
Ibipinabant
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Ibipinabant.
Rifapentine
Ajulemic acid
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Ajulemic acid.
Rifapentine
GW842166
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with GW842166.
Rifapentine
Cannabidiol
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Cannabidiol.
Rifapentine
Taranabant
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Taranabant.
Rifapentine
Rimonabant
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with Rimonabant.
Rifapentine
SLV319
The risk or severity of Tachycardia and drowsiness can be increased when Fesoterodine is combined with SLV319.
Rifapentine
Cimetropium
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Cimetropium.
Rifapentine
Otilonium
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Otilonium.
Rifapentine
Agmatine
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Agmatine.
Rifapentine
Solifenacin
The risk or severity of adverse effects can be increased when Solifenacin is combined with Fesoterodine.
Rifapentine
Timepidium
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Timepidium.
Rifapentine
Pipenzolate
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Pipenzolate.
Rifapentine
Emetonium iodide
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Emetonium iodide.
Rifapentine
Fenpiverinium
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Fenpiverinium.
Rifapentine
Camylofin
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Camylofin.
Rifapentine
Diphemanil
The risk or severity of adverse effects can be increased when Fesoterodine is combined with Diphemanil.